Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol., 12 February 2019

Sec. Cellular Endocrinology

Volume 10 - 2019 | https://doi.org/10.3389/fendo.2019.00073

RETRACTED: LRP6 Knockdown Ameliorates Insulin Resistance via Modulation of Autophagy by Regulating GSK3β Signaling in Human LO2 Hepatocytes

Retracted

Lei Li,Lei Li1,2Jing XueJing Xue1Jipeng WanJipeng Wan1Qian ZhouQian Zhou1Shan WangShan Wang1Yu ZhouYu Zhou1Heyong Zhao*Heyong Zhao3*Xietong Wang,,*Xietong Wang1,3,4*
  • 1Department of Obstetrics and Gynaecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
  • 2Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
  • 3Maternal and Child Health Care of Shandong Province, Jinan, China
  • 4Key Laboratory of Birth Regulation and Control Technology of National Health and Family Planning Commission of China, Jinan, China

Citation: Li L, Xue J, Wan J, Zhou Q, Wang S, Zhou Y, Zhao H and Wang X (2019) LRP6 Knockdown Ameliorates Insulin Resistance via Modulation of Autophagy by Regulating GSK3β Signaling in Human LO2 Hepatocytes. Front. Endocrinol. 10:73. doi: 10.3389/fendo.2019.00073

Received: 29 August 2018; Accepted: 25 January 2019;
Published: 12 February 2019; Retracted: 27 November 2025.

Edited by:

Timo Dirk Müller, Helmholtz Center Munich-German Research Center for Environmental Health, Germany

Reviewed by:

Fouad Janat, Independent Researcher, Westerly, RI, United States
Benyi Li, University of Kansas Medical Center, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.